Dr. Wenqing Yang, CSO, Invited to Attend the Second International Congress on Clinical Immunology and Allergy (ICIA 2023)
2023-10-27
From October 23-25, 2023, the second International Congress on Clinical Immunology and Allergy (ICIA) was grandly held in Boston, USA. Dr. Wenqing Yang, our company's CSO, attended the event as a member of the Scientific Committee on behalf of ClinBridge Bio.
ICIA is an international immunology conference that brings together top experts in the fields of immunology and allergy, pharmaceutical R&D enterprises, researchers, and physicians. Its aim is to promote the exchange of the latest research in clinical immunology and allergies. Dr. Yang's participation in the Scientific Committee and attendance at the congress provide our company with significant opportunities to actively participate in and advance the forefront of research in this field.
As a member of the Scientific Committee, Dr. Yang was involved in organizing and evaluating presentations, research papers, and discussion panels during the conference, ensuring the content was of high quality and substantial scientific value. He also collaborated with other international experts in immunology and allergy to promote the sharing and discussion of the latest scientific findings.
Dr. Yang is a distinguished expert in translational science, with significant influence in the fields of tumor immunology and autoimmune diseases. His invitation to the international congress’s Scientific Committee is a recognition of his outstanding contributions and leadership in the field. Dr. Yang actively participated in collaborative projects during the conference, working with international colleagues to address challenges in immunology and allergy. His contributions have strengthened our company’s reputation in relevant scientific and research fields and robustly supported our mission.
联科
Official Public Number
Copyright©2023 Nanjing Yunqiao Purui Biotechnology Co., Ltd.
